SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-566075
Filing Date
2016-04-29
Accepted
2016-04-29 07:31:05
Documents
8
Period of Report
2016-06-15
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d120869ddef14a.htm DEF 14A 337159
2 GRAPHIC g120869g62k76.jpg GRAPHIC 20634
3 GRAPHIC g120869g91c62.jpg GRAPHIC 28220
4 GRAPHIC g120917g11y77.jpg GRAPHIC 26592
5 GRAPHIC g120917g21j11.jpg GRAPHIC 24658
6 GRAPHIC g120917g56z83.jpg GRAPHIC 16586
7 GRAPHIC g120917g57f70.jpg GRAPHIC 22487
8 GRAPHIC g120917g82x90.jpg GRAPHIC 39938
  Complete submission text file 0001193125-16-566075.txt   585701
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 161602490
SIC: 2834 Pharmaceutical Preparations